Kristina Unnebrink - Concepedia

Author

Kristina Unnebrink

Also Known As

Caren Bellmann, G. R. Burmester, J Munzinger, K Unnebrink, K. Unnebrink, Kristina Unnebrink, S. Kary, Unnebrink, Kristina

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

AbbVie (Germany)Heidelberg University AbbVie (United States)Abbott (Germany)Charité - Universitätsmedizin Berlin

About

Kristina Unnebrink is an author at AbbVie (Germany) specializing in medicine, age-related diseases, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	949
2	Engineering	1	1	23
3	Public Health	1	1	141
4	Social Sciences	1	1	65
5	Anesthesia	1	1	99

Kristina Unnebrink

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) J.‐H. Saurat, G Stingl, Louis Dubertret, British Journal of Dermatology	2007	719
Intention‐to‐treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases Kristina Unnebrink, Jürgen Windeler Statistics in Medicine Disease ManagementMeta-analysisClinical EffectivenessHealth PolicyControlled Clinical Trials	2001	256
A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis Kristian Reich, Richard G. Langley, Kim Papp, New England Journal of Medicine	2011	196
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial Gerd R Burmester, X. Mariette, Carlomaurizio Montecucco, Annals of the Rheumatic Diseases	2007	196
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice Stefano Bombardieri, A. A. Ruiz, Patrice Fardellone, Lara D. Veeken	2007	178
Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis Victoria Bejarano, Mark Quinn, Philip G. Conaghan, Arthritis Care & Research	2008	170
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial Kim Papp, Diamant Thaçi, Danielle Marcoux, The Lancet Systemic TreatmentClinical TrialsPediatricsClinical DermatologyPharmacotherapy	2017	147
Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure Alexander Hansen, Markus Haass, Christian Zugck, Journal of the American College of Cardiology Heart FailureCardiovascular DiseaseMyocardial InfarctionPrognostic ValueCardiac Care	2001	141
Final Report of the Early vs. Late Infantile Strabismus Surgery Study (ELISSS), a Controlled, Prospective, Multicenter Study Huibert J. Simonsz, G. Kolling, Kristina Unnebrink Strabismus	2005	141
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study Diamant Thaçi, J.‐P. Ortonne, Sergio Chimenti, British Journal of Dermatology Topical TherapiesMedicineSevere PsoriasisClinical TrialsClinical Dermatology	2010	111

Page 1